A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells

BACKGROUND AIMS: The PR1 peptide, derived from the leukemia-associated antigens proteinase 3 and neutrophil elastase, is overexpressed on HLA-A2 in acute myeloid leukemia (AML). We developed a T cell receptor (TCR)-like monoclonal antibody (8F4) that binds the PR1/HLA-A2 complex on the surface of AM...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cytotherapy
Egile Nagusiak: Ma, Qing, Garber, Haven R., Lu, Sijie, He, Hong, Tallis, Eran, Ding, Xiaoling, Sergeeva, Anna, Wood, Michael S, Dotti, Gianpietro, Salvado, Barbara, Ruisaard, Kathryn, Clise-Dwyer, Karen, John, Lisa St, Rezvani, Katayoun, Alatrash, Gheath, Shpall, Elizabeth J., Molldrem, Jeffrey J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4935572/
https://ncbi.nlm.nih.gov/pubmed/27265873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2016.05.001
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak